Furthermore, we provide evidence that GSK3β is able to bind to EZH2 in vitro and that inhibition of GSK3β activity is associated with excessive EZH2 production, which may enhance the local invasion capacity of NPC cells. The gene discussed is GSK3B; the disease is nasopharyngeal carcinoma.